Enhancement of platelet deposition by cross-linked hemoglobin in a rat carotid endarterectomy model

Circulation

Volumn 93, Issue 2, 1996, Pages 327-332

  Olsen, Stephen B ^a   Tang, Douglas B ^a   Jackson, Mark R ^a   Gomez, Edward R ^a   Ayala, Benjamin ^a   Alving, Barbara M ^a,b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

hemoglobin; nitric oxide; platelets; surgery

Indexed keywords

ACETYLSALICYLIC ACID; ARGININE; HEMOGLOBIN; INDIUM 111; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; BLEEDING TIME; BLOOD VESSEL INJURY; CAROTID ENDARTERECTOMY; CELL LABELING; CONTROLLED STUDY; HEMODYNAMICS; HEMOGLOBIN DETERMINATION; INFUSION; INTIMA; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; MICROSURGERY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION;

EID: 0030032932     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.2.327     Document Type: Article

References (31)

1. Shoemaker SA, Gerber MJ, Evans GL, Archer-Pail LE, Scoggin CH. Initial clinical experience with a rationally designed, genetically engineered recombinant human hemoglobin. Artif Cells Blood Substit Immobil Biotechnol. 1994;22:457-465.
2. Salvemini D, Radziszewski W, Korbut R, Vane J. The use of oxyhaemogiobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO-donors. Br J Pharmacol. 1990;101:991-995.
3. Murad F, Mittal CK, Arnold WP, Katsuki S, Kimura H. Guanylate cyclase activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. Adv Cyclic Nucleotide Res. 1978;9:145-158.
4. Keipert PE, Gonzales A, Gomez CL, MacDonald VW, Hess JR, Winslow RM. Acute changes in systemic blood pressure and urine output of conscious rats following exchange transfusion with diaspirin-crosslinked hemoglobin solution. Transfusion. 1993;33: 701-708.
5. Hamilton I, Schultz SC, Cole F, Burhop K, Malcolm D. Characterization of diaspirin cross-linked hemoglobin's pressor response. Crit Care Med. 1992;20:S106. Abstract.
6. Hess JR, MacDonald VW, Brinkley WW. Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol. 1993;74:1769-1778.
7. Przybelski RJ, Malcolm DS, Burris DG, Winslow RM. Cross-linked hemoglobin solution as a resuscitative fluid after hemorrhage in the rat. J Lab Clin Med. 1991;117:143-151.
8. Schultz SC, Grady B, Cole F, Hamilton I, Burhop K, Malcolm DS. A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med. 1993;122: 301-308.
9. Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 1987;2:1057-1058.
10. Radomski MW, Palmer RMJ, Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun. 1987;148:1482-1489.
11. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
12. Radomski MW, Palmer RMJ, Moncada S. Characterization of the L-arginine:nitric oxide pathway in human platelets. Br J Pharmacol. 1990;101:325-328.
13. Hogan JC, Lewis MJ, Henderson AH. In vivo EDRF activity influences platelet function. Br J Pharmacol. 1988;94:1020-1022.
14. Chapman KW, Snell KM, Jesse RG, Morano JK, Everse J, Winslow RM. Pilot scale production of pyrogen-free human hemoglobin for research. Biomater Artif Cells Immobil Biotechnol. 1992;20:415-421.
15. Bauman JM, Landry AJ. Practical platelet labeling with indium-111-oxine. J Nucl Med Technol. 1986;14:15-17.
16. Hamelink JK, Tang DB, Barr CF, Jackson MR, Reid TJ, Gomez ER, Alving BM. Inhibition of platelet deposition by combined Hirulog and aspirin in a rat carotid endarterectomy model. J Vasc Surg. 1995;21:492-498.
17. Sasaki T, Kassell NF, Turner DM, Yamashita M, Spallone A. Microsurgical carotid endarterectomy in rats. Neurosurgery. 1984; 15:683-689.
18. Armitage P, Berry G. Statistical Methods in Medical Research. 2nd ed. Boston, Mass: Blackwell Scientific Publications; 1987:90-92.
19. Glantz SA, Slinker BK. Primer of Applied Regression and Analysis of Variance. New York, NY: McGraw-Hill Co; 1990:272-313.
20. Minitab Inc. Minitab Reference Manual, Release 9 (for Windows). State College, Pa: 1993.
21. Broekman MJ, Eiroa AM, Marcus AJ. Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension: blockade of aggregation and secretion by an aspirin-insensitive mechanism. Blood. 1991;78:1033-1040.
22. MacDonald JD, Remington BJ, Rodgers GM. The skin bleeding time test as a predictor of brain bleeding time in a rat model. Thromb Res. 1994;76:535-540.
23. De Caterina R, Lanza M, Manca G, Buti-Strata G, Maffei S, Salvatore L. Bleeding time and bleeding: an analysis of the relationship of the bleeding time test with parameters of surgical bleeding. Blood. 1994;84:3363-3370.
24. Rodgers RPC, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost. 1990;16:1-20.
25. Lind S. The bleeding time does not predict surgical bleeding. Blood. 1991;77:2547-2552.
26. Beller FK, Theiss W. Fibrin derivatives, plasma hemoglobin and glomerular fibrin deposition in experimental intravascular coagulation. Thromb Diathes Haemorrh. 1973;29:363-374.
27. Lalla FR, Ning J, Chang JMS. Effects of pyridoxylated polyhemoglobin and stroma free hemoglobin on ADP induced platelet aggregation. Biomater Artif Cells Artif Organs. 1989;17:363-368.
28. Reiss RF, Cabellero R, Hess J. Effects of X-linked hemoglobin on in-vitro platelet function. Biomater Artif Cells Immobil Biotechnol. 1992;20:651-655.
29. G-Monomethyl-L-arginine increases platelet deposition on damaged endothelium in vivo: a scanning electron microscopy study. Thromb Res. 1991;64: 1-9.
30. Yao S-K, Ober JC, Krishnaswami A, Ferguson JJ, Anderson V, Golino P, Buja LM, Willerson JT. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation. 1992;86:1302-1309.
31. Groves PH, Lewis MJ, Cheadle HA, Penny WJ. SIN-1 reduces platelet adhesion and platelet thrombus formation in a porcine model of balloon angioplasty. Circulation. 1993;87:590-597.